A study using single-cell transcriptomics and mapping of expression quantitative trait loci (eQTLs) in a dynamic model of CD4+ T cell activation reveals novel, context-specific eQTLs linked to genes associated with immune diseases such as inflammatory bowel disease.
Your institute does not have access to this article
Access options
Subscribe to Nature+
Get immediate online access to the entire Nature family of 50+ journals
$29.99
monthly
Subscribe to Journal
Get full journal access for 1 year
$59.00
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.

References
Cano-Gamez, E. et al. Single-cell transcriptomics identifies an effectorness gradient shaping the response of CD4+ T cells to cytokines. Nat. Commun. 11, 1801 (2020). Though the use of single-cell transcriptomics, this work demonstrated that T cells form a continuum of cell types and states.
Soskic, B. et al. Chromatin activity at GWAS loci identifies T cell states driving complex immune diseases. Nat. Genet. 51, 1486–1493 (2019). This work showed that immune-disease variants undergo enrichment for active chromatin regions that are upregulated after T cell activation.
Fang, H. et al. A genetics-led approach defines the drug target landscape of 30 immune-related traits. Nat. Genet. 51, 1082–1091 (2019). This work used a genetics-led approach to identify known drug targets for immune traits and nominate new ones.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This is a summary of: Soskic, B. et al. Immune disease risk variants regulate gene expression dynamics during CD4+ T cell activation. Nat. Genet. https://doi.org/10.1038/s41588-022-01066-3 (2022).
Rights and permissions
About this article
Cite this article
A molecular map of T cell activation gives insights into immune disease. Nat Genet 54, 752–753 (2022). https://doi.org/10.1038/s41588-022-01067-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41588-022-01067-2